I decided to look at something new: Vwap: Week, Month, and Year. I have highlights of two patterns following different setups but similar Indicator patterns. **Also Yes I am aware the VWAP Year is not that impressive from only being a month and a half into the year!! Notes: -Notice the Flat top Breakout (FTB) in the first shaded area 3 taps per normal healthy...
I will keep this one simple. We are closing in on a major bullish breakout. As we approach the top of the larger daily flag, you can see the smaller time frame Flat top setup. Here is the beautiful part of this pattern in pattern play. we are sitting on Super strong support of the 9EMA, Its tight Its right! That 9 EMA will help push through the Flat top for a...
Welcome Hyperspace Archaeologists, Come for the laughs, stay for the Art. ___________________ Find the "we are here" bubble. I am most likely wrong... Meh . Who cares. but what... if.. good enough for me! All in. #pewpeww __________________________________ Trade Taken: Entry Range is $2.38 - $2.45 Target $8.60 Hold until April 2021 Technical. One Cajun Ship...
VRTX up after exceeding earnings on JAN 30, finds support at 240. 5 day moving average is strong. Double inverted head and shoulders signals strong buy, possible breakout. Entry at 243, target price 252, stop loss 241.
Firdapse Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020 Firdapse MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020 Short Float = 13.23% Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside...
Patent covering the use of Blue Light Cystoscopy (BLC®) with Hexvix as neoadjuvant* therapy in the treatment of bladder cancer in patients who are scheduled for a cystectomy. Early stage study results have shown an antitumor effect and induced systemic immune effects of hexaminolevulinate (HAL) and blue light in an orthotopic model of rat bladder cancer....
We are ready!!! The presentation today will create the catalyst needed for Greatness and Glory!!! We have put up with that Bear crap for the last time, now lets make us some millionaires and cure some F**kin Cancer!! Notes: OBV: About to Break through top of its Trend! -Chart shows a slightly modified(Accelerated) Price projection. -Coming out a strong...
I noticed a very similar pattern on the Daily where the 9 and 50 MA cross and where the 20 MA will soon Cross. This is an super simple attempt to project what will happen... The Presentation next week would align well with a breakout!! Good luck and buy those bags while they are cheap!!
The 4hr chart looks promising for a decent Scalp. 9,20, and 50 EMA curling up under the price. -9 EMA just crossed the 20 EMA and both the 9 and 20 EMA are about to cross the 50 EMA Targets: - .62 take out 1/2 - .81 all out Lets see how we do!
3 new ipo this week. All of these expected to be good.
Its been a while since I have published anything but this stock is ready for greatness and glory!! With upcoming news on the horizon ( presentation coming up) and a lot of speculation on potential Merck acquisition. The TA combined is ready to rocket!!! Notes: -200, 50, 20, and 9 EMA all curling right under the price(Curls for the girls).. This indicates a...
Strong market, strong XBI, weak APLT. I believe this can be the beginning of the reversal back to reality for this stock back to $40 or lower. *Speculation burns **Short
Long $TEVA to at least $12 this week on technical basis alone. Could go for $15-$20 into March depending on earnings report on 2/12. DYOD - do your own due-diligence.
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Is yet again testing the resistance at 200. The grey area is a 5 year previous Support/resistance zone, been tested multiple times. Break out could lead to a significant rally...
just a new Idea. See the text on the chart. Buying on first-second day still might be a good option.
The Beijing branch of China’s National Health Commission said a combination of lopinavir and ritonavir, sold under the brand name Kaletra by AbbVie, is part of its latest treatment plan for patients infected by the Coronavirus, which has killed at 81 people in China and sickened more than 2,800 worldwide. After breaking out of the downtrend, ABBV is coming back...